Background: The aim of this study was to assess the salivary content of lipid peroxidation and antioxidants in patients with type 2 diabetes. Method: We studied 25 patients with type 2 diabetes and other 25 age-and sex-matched health control. To evaluate the oxidative status we measured the levels of malondialdehyde (MDA) in the saliva and serum of all participants. Lipid profile was also estimated through measuring total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and very low-density lipoprotein cholesterol (VLDL-C) levels. Antioxidant levels were also assessed through measuring the salivary and serum concentration of uric acid, superoxide dismutase and reduced glutathione (GSH). Results: The high concentration of lipid fractions in saliva usually follows that recorded in serum. Salivary MDA levels, a product of lipid peroxidation, were significantly increased among diabetics together with uric acid. However, GSH levels were similar to those of the control group. Conclusion: Lipid peroxidation and antioxidant parameters assessed in saliva of diabetic patients may be of great importance in evaluating the disease activity and severity. The increase in lipid peroxidation and the tendency of antioxidants to rise in diabetes is probably due to an adaptive response to the pro-oxidant status of diabetes.
Introduction
Type 2 diabetes (non-insulin-dependent diabetes) is a multicausal disease which develops slowly and in a stepwise order. [1] [2] [3] Initially it commences with insulin resistance, which progress gradually with time until the body fails to maintain glucose haemostasis resulting in glucose intolerance. Systemically these perturbations are accompanied with changes in a variety of biochemical processes such as obesity, an altered lipid profile and lipid peroxidation. 4 Oxidative damage to unsaturated lipids is a well-established general mechanism for oxidative stress-mediated cellular injury, 5 in addition to increased lipid peroxidation. 6 The occurrence of free-radical-induced lipid peroxidation causes considerable changes in the cell membrane. 7 Peroxidation of the lipid membrane has been related to the pathogenesis of many degenerative diseases, such as atherosclerosis, aging, carcinogenesis and diabetes mellitus. 8 Evidence suggests that oxidative stress is increased in diabetes, because of excessive production of reactive oxygen species (ROS) and an impaired antioxidant defence mechanism. 9, 10 It has been suggested that ROS induce membrane lipid glutathione (GSH) act as potent electron donors; they donate hydrogen atoms to pair up with unpaired electrons on free radicals. Thus, they convert reactive free radicals into inactive substances. 13 The determination of the oxidative stress and antioxidants require sometimes invasive techniques such as taking blood samples. Whole saliva is an important physiologic fluid that contains a highly complex mixture of substances. Variable amounts of blood, serum products are present in whole saliva. 14 Exploring saliva for oxidative stress and antioxidant markers that accurately reflect the redox status of the body may have great clinical interest. Research on salivary antioxidant remains limited, and conflicting data have been reported. Moore et al. 15 measured the antioxidant capacity of saliva in periodontally diseased and healthy individuals and failed to find any significant difference between the groups. Moreover, no significant correlations were found between the total antioxidant capacity of saliva and age or flow rate, regardless of periodontal status. 16 Accordingly, we considered it worthwhile to examine the salivary content of lipid peroxidation and antioxidants such as UA, SOD and GSH in patients with type 2 diabetes looking for markers that accurately reflect the severity of the oxidative stress and allow the evolution of the disease to be followed.
Patients and methods
Fifty consented individuals were enrolled in this observational study. They were grouped into two groups, and the study group consisted of 25 patients (12 males and 13 females) with type 2 diabetes mellitus without complications. They were recruited during their routine medical care visits from an outpatient diabetic clinic at Al-Diwaniya hospital. All patients with diabetes were being treated with stable doses of oral hypoglycaemic agents. The control group consisted of 25 (12 males and 13 females) systemically healthy subjects aged 40-60 years. We the full medical history of all individuals and clinical examinations with laboratory investigations were undertaken to exclude any other systemic and/or local diseases that may affect the parameters examined in this study. Oral and periodontal examination was performed for each individual and anyone with symptoms and signs of any active oral inflammation, advanced periodontitis or severe gingivitis was excluded from the study. The study protocol was explained and informed written consent was received from each individual before their enrolment in the study. The study was approved by the Institutional Ethical Committee of Al-Diwaniya Teaching hospital.
Saliva and serum sampling
Saliva samples were obtained in the morning after overnight fast, during which subjects were requested not to drink (except water) or chew gum. The whole saliva was obtained by expectoration in polypropylene tubes prior to clinical measurement. The collection time was 5 minutes. Venous blood samples were taken from each patient with diabetes mellitus and analysed for fasting blood glucose. Saliva and serum samples were cold centrifuged at 3000 rpm at 4°C for 5 minutes. The supernatant was aspirated and stored at -20°C until analysed.
Laboratory analysis
Total cholesterol (TC) and triglycerides concentration in saliva and serum were measured using enzymatic methods. 17, 18 The high-density lipoprotein cholesterol (HDL-C) concentration was measured using the method described by Warnick et al. 19 Low-density lipoprotein cholesterol (LDL-C) concentration was then calculated from the concentration of TC, HDL-C and triglycerides using the method of Friedwald and Levy. 20 Salivary and serum lipid peroxidation products, MDA, was measured using the method outlined by Buege and Aust 21 where MDA reacts with thiobarbituric acid (TBA) to yield a pink-coloured product. The absorbance of 3 ml coloured layer was measured at 335 nm spectrophotometrically. GSH levels were determined by a colorimetric microplate assay and according to the method described by Burtis and Ashwood. 22 The reaction kinetics were measured by determining the rate of colour change at 450 nm. SOD levels were assessed using a modified photochemical nitroblue tetrazolium (NBT) method utilising sodium cyanide as a peroxidase inhibitor, 23 and UA level was measured using an enzymatic method utilising available kits from bioMERIUX (France).
All data were analysed with SPSS-17 (Chicago, IL-USA). The significance of difference in the mean between groups was calculated using Student's t-test. The Spearman correlation equation was applied to test the type and significance of relations among parameters in both serum and saliva. A p-value < 0.05 was considered statistically significant.
Results
The results of the present study are described in Tables 1-4 . The mean age of the control group was 50 ± 6 years and for the diabetic group was 54 ± 7 years. The fasting blood sugar (FBS) in the diabetic group was 8.25 ± 0.77 mmol/l and for the control group was 5.1 ± 1.1 mmol/l. Based on serum levels of TC and triglycerides, all subjects in the diabetic group were hyperlipidemic (TC > 4.5 and triglyceride 1.7 mmol/l). Subjects in the control group, on the other hand, were normolipidemic (TC < 4.5 and triglycerides < 1.7 mmol/l). The cholesterol and triglyceride concentrations in serum and saliva were substantially increased in the diabetic group as compared with the control group (p < 0.001). The concentrations of LDL-C and very low-density lipoprotein cholesterol (VLDL-C) were significantly high and the concentrations of HDL-C were significantly low among diabetics (Figures 1 and 2) . The serum and salivary MDA levels, a product of lipid peroxidation, is increased significantly among diabetics ( Figure 3 ).
Antioxidant activity was assessed in this study through measuring the concentration of US, SOD and GSH reductase in the serum and saliva of diabetic and control groups (Tables 1  and 2 ). The mean values of serum and salivary UA of healthy control were 358.36 ± 38.9 and 209.9 ± 28.3 µmol/l, respectively. In the diabetic group, serum values ranged from 369 to 584 µmol/l with a mean of 461.2 ± 58.8 µmol/l and salivary levels ranged from 188 to 520 µmol/l with a mean value of 350.8 ± 90.4 µmol/l (Figure 4 ). Salivary SOD activity in the diabetic group was doubled in comparison with the control group. Serum GSH activity was significantly low among diabetics; however, salivary GSH levels were similar to those of control group ( Figures 5 and 6 and Table 2 ). As shown in Table 3 , serum TC had significantly strong positive correlation (r = 0.97) with serum LDL-C only among diabetics, whereas serum triglycerides had significantly moderate to strong negative correlation with serum HDL-C (r = -0.466) and serum GSH had a positive relation with serum SOD only.
Salivary lipid parameters showed a significant direct relation between TC with LDL-C as well as VLDL-C with a significant negative (inverse) relation with HDL-C; salivary VLDL-C had a negative relation with salivary SOD only ( Table 4) . The relation between the tested parameters in saliva with that in the serum of diabetics is shown in Table 5 , salivary triglyceride had a significant direct relationship with serum VLDL-C and a significant inverse relationship with serum HDL-C (p < 0.05). Salivary MDA had a weak positive relation with serum UA and salivary SOD had a weak positive relation with serum GSH (p < 0.05).
Discussion
In diabetes mellitus, abnormally increased levels of lipids, lipoproteins and lipid peroxides in plasma may be due to the abnormal lipid metabolism. 8 Patients with type 2 diabetes frequently have an abnormal blood lipid profile consisting of moderately elevated LDL-C, moderately decreased HDL-C, and high TC and triglycerides. Thus, inadequate levels of HDL-C, in conjunction with more atherogenic forms of LDL-C may contribute to atherogenesis. 24 The results of the present study showed a two-fold increase in serum levels of all lipid fractions (except for HDL-C) for diabetic group when compared with control group. The various compositional changes in saliva currently demonstrated indicate that salivary glands are targeted organs in diabetes mellitus. The high concentrations of lipid fractions in saliva recorded in this study usually follow those recorded in serum which is significantly different from that of the control group. This may clarify that the salivary lipid profile in diabetic patients may result from a state of systemic dyslipidemia and serum composition is reflected in the saliva composition. Hypertriglyceridemia and hypercholesterolemia were associated with oxidative modification of LDL-C, protein glycation and glucose autooxidation, thus leading to excess production of lipid peroxidation products which may cause elevation of oxidative stress in higher lipid and hyperlipidemic subjects. 25 Enhanced oxidative stress was indicated by increased free radicals production, 26 lipid peroxidation and reduced antioxidant status. 27 Several studies have reported an increased susceptibility to lipid peroxidation in patients with diabetes mellitus. 28 The generation of free radicals may lead to lipid peroxidation and the formation of several types of damage in diabetes mellitus. In the present study, we have observed that MDA levels, a lipid peroxidation product and a marker of oxidative stress, were elevated significantly in diabetic patients. 29 Salivary MDA levels are directly affected by systemic oxidative stress, since MDA levels were also elevated in the saliva of diabetic patients. The salivary MDA level was significantly increased in the diabetic group of the present study which reflects a high oxidative stress status among diabetic patients. Salivary estimation of lipid peroxide along with other lipid profiles in diabetes mellitus is therefore considered very useful as it may serve as a useful monitor to judge the lipidemic status of the patients.
UA is the end product of purine metabolism; it can act as a pro-oxidant, particularly at increased concentration and may thus be a marker of oxidative stress, 30, 31 but it may also have a therapeutic role as an antioxidant. 32, 33 Thus, it is unclear whether the increased concentration of UA in diseases associated with oxidative stress, such as diabetes mellitus, are a protective response or a primary cause. It is worth noting that hyperuricemia has been found to be associated with obesity and insulin resistance and consequently with type 2 diabetes mellitus. [34] [35] [36] Chen et al., 37 in a well-conducted large population study, investigated the association between plasma concentration of UA and the incidence of type 2 diabetes mellitus in Chinese subjects. The significant increase and the direct relationship between salivary UA and MDA in the present study indicate that this previously antioxidant serum and salivary UA paradoxically becomes pro-oxidant. 37 The diabetes-induced salivary oxidative damage reported is novel, as is the altered salivary antioxidant profile. The overall salivary antioxidants increase in DM patients may result from a state of systemic oxidative stress, which induced a general increase in serum antioxidant, as to a large extent serum composition is reflected in the saliva composition. However, this oxidative stress consumes some naturally occurring local antioxidants such as reduced GSH, and the antioxidant activity of salivary GSH in the present study was significantly reduced compared with control values. The significant decrease in serum and salivary GSH as well as increase or decrease of other antioxidants in this study reflects the overwhelming adaptive response to the challenge of oxidative stress in the diabetic state with or without complication. One advantage of this study is the selection of a group with diabetes presenting with clinically healthy periodontium, which enabled us to conclude that the levels of salivary antioxidants are definitely related to the diabetic status, independently of the clinical periodontal situation. Gumus et al. 38 evaluated and compared salivary concentration of reduced GSH, UA, ascorbic acid and total antioxidant capacity in diabetic and systemically healthy individuals with inflammatory periodontitis and found that the decrease in salivary reduced GSH levels only in patients with type I diabetes mellitus may have a role in periodontal tissue destruction by predisposing tissues to oxidative stress. Sailaja et al. 39 reported that diabetic humans have shown increased lipid peroxidation and decreased levels of reduced GSH, glutathione reductase and glutathione peroxidase. These data suggest that the oxidative stress in these pathologies does not depend on a loss of GSH or a lack of GSH synthesis alone, but a misbalance in the oxidant/reduction cycle of GSH. 40 The increased serum and salivary levels of antioxidants (UA and SOD) among diabetics in the present study may be explained on the basis that the existence or increased free radicals production may enhance the antioxidant defence system which counter-balances the pro-oxidant environment. Reznick et al. 41 have shown that oxidative stress exists in diabetic patients as evidenced by the increased total antioxidant capacity in the saliva and blood of patients. Indeed, there is evidence that suggests that endogenous antioxidant capacity is eroded in diabetes, due to several factors, including the impact of non-enzymatic glycation on key enzymes, the polyol pathway and its consumption of reducing power, as well as the constant demands of oxidative stress. [42] [43] [44] [45] [46] [47] The present study showed that elevated serum and salivary endogenous antioxidant activity among diabetics is a response to the damaging effect of free radicals release due to increased oxidative stress. Indeed, the detection of increases in UA levels in saliva should therefore alert clinicians to the commensurately increased vulnerability of the diabetic patient to life-threatening cardiovascular complications.
In conclusion, the assay of salivary oxidative stress parameters has brought substantial insight into the pathogenesis and evolution of diabetes. Thus, subjects at high risk of developing hyperlipidemia may benefit from treatment with antioxidants such as vitamin E and C, which might assist endogenous antioxidant capacity and reduce peroxidation rates. Whether such supplementation might possibly delay or even prevent complications of this disease is an area of ongoing investigation.
